PREDICT Tool Version 2.0: Breast Cancer Survival; Results
Five year survival 52 out of 100 women are alive at 5 years with no adjuvant therapy after surgery
An extra 12 out of 100 women treated are alive because of hormone therapy
An extra 0 out of 100 women treated are alive because of chemotherapy
An extra 12 out of 100 women treated are alive because of hormone therapy & chemotherapy
An extra 20 out of 100 women treated are alive because of hormone therapy, chemotherapy & Trastuzumab Ten year survival 18 out of 100 women are alive at 10 years with no adjuvant therapy after surgery
An extra 13 out of 100 women treated are alive because of hormone therapy
An extra 0 out of 100 women treated are alive because of chemotherapy
An extra 13 out of 100 women treated are alive because of hormone therapy & chemotherapy
An extra 25 out of 100 women treated are alive because of hormone therapy, chemotherapy & Trastuzumab
To view the numbers in bars hover pointer over each bar-segment
(Or tap segment if using a mobile device)
Year
Survival with no Adjuvant treatment
Benefit of Adjuvant Hormone therapy
Five years
51.9
11.7
Ten years
17.7
12.6
Overall Survival at 5 and 10 years (percent)
Disclaimer: PREDICT can only
provide a general guide to possible outcomes in any individual case. As
we are all different, for the more complete picture in your case, you
should speak to your own specialist. You may wish to print this page
out and share it with your specialist.
